FREAMINE III 8.5% Drug Patent Profile
✉ Email this page to a colleague
When do Freamine Iii 8.5% patents expire, and when can generic versions of Freamine Iii 8.5% launch?
Freamine Iii 8.5% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in FREAMINE III 8.5% is amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate profile page.
Summary for FREAMINE III 8.5%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FREAMINE III 8.5% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FREAMINE III 8.5%
US Patents and Regulatory Information for FREAMINE III 8.5%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | FREAMINE III 8.5% | amino acids | INJECTABLE;INJECTION | 016822-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun | FREAMINE III 8.5% W/ ELECTROLYTES | amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate | INJECTABLE;INJECTION | 016822-007 | Jul 1, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |